Improvements in Non-Invasive Biomarkers & Their Correlation to Histology: Significance of Eliminating the Disease Driver in Achieving a Sustained Benefit

Time: 9:30 am
day: Seminar B- AM tracks


  • Discuss the importance of consistency of effect across the different markers of NASH pathophysiology including liver fat, liver injury and fibrosis
  • Discuss the normalization of non-invasive parameters with EFX and correlation with histologic improvement
  • Significance of eliminating underlying disease drivers to achieve a sustained response